Development and Optimization of PEGylated Darolutamide-Loaded Liposomes for Treatment of Prostate Cancer: in Vitro and in-vivo Characterization
Crossref DOI link: https://doi.org/10.1007/s12247-025-10352-6
Published Online: 2026-02-13
Published Print: 2026-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Patil, Vinod
Pawar, Harshal
Text and Data Mining valid from 2026-02-13
Version of Record valid from 2026-02-13
Article History
Received: 24 July 2025
Accepted: 24 December 2025
First Online: 13 February 2026
Declarations
:
: The authors declare no competing interests.